Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors
NCT01302405
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
23
Enrollment
INDUSTRY
Sponsor class
Stopped
closing due to low enrollment, no safety issues
Conditions
Advanced Solid Tumors
Interventions
DRUG:
PRI-724
Sponsor
Prism Pharma Co., Ltd.
Collaborators
[object Object]